ION™ Paclitaxel-Eluting Platinum Chromium
Coronary Stent System
A New Standard for Treatment of Acute MI
There’s only one drug-eluting stent indicated for AMI, and that’s the ION Stent from Boston Scientific. The HORIZONS-AMI trial has led to an indication for AMI, giving you one more reason to confidently choose the ION Stent for your patients.
A New Standard in Performance
The ION™ Stent, with its innovative Platinum Chromium (PtCr) alloy, new stent design and delivery system, sets a new standard in strength, deliverability, and visibility.
 |
View the ION™ Paclitaxel-Eluting Platinum Chromium |
Want to learn more about the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent?
Prior to use, please see the complete "Directions for Use" for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator's Instructions. View ION Stent Prescriptive Information »
IC-28504-AB SEP2012